Circulating cell-free DNA (cfDNA) has attracted attention as a non-invasive biomarker for diagnosing and monitoring various cancers. Given that human papillomavirus (HPV) DNA integration and overexpression of E6/E7 oncogenes are pivotal events for carcinogenesis, we sought to determine if HPV E7 cfDNA could serve as a specific biomarker for cervical cancer detection. We applied droplet digital PCR (ddPCR) to quantify HPV16/18 E7 cfDNA from the serum of patients with cervical cancer, cervical intraepithelial neoplasia, and controls. HPV16/18 E7 cfDNA was highly specific for cervical cancer, displaying 30.77% sensitivity, 100% specificity, and an area under the curve of 0.65. Furthermore, we developed a sensitive isothermal detection of HPV16/18 E7 and the PIK3CA WT reference gene based on recombinase polymerase amplification combined with a lateral flow strip (RPA-LF). The assay took less than 30 min and the detection limit was 5–10 copies. RPA-LF exhibited 100% sensitivity and 88.24% specificity towards HPV16/18 E7 cfDNA in clinical samples. The agreement between RPA-LF and ddPCR was 83.33% (κ = 0.67) for HPV16 E7 and 100% (κ = 1.0) for HPV18 E7, indicating a good correlation between both tests. Therefore, we conclude that HPV E7 cfDNA represents a potential tumor marker with excellent specificity and moderate sensitivity for minimally invasive cervical cancer monitoring. Moreover, the RPA-LF assay provides an affordable, rapid, and ultrasensitive tool for detecting HPV cfDNA in resource-limited settings.
BrayFFerlayJSoerjomataramISiegelRLTorreLAJemalA.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin2018;
68:394–424
2.
BermanTASchillerJT.Human papillomavirus in cervical cancer and oropharyngeal cancer: one cause, two diseases. Cancer2017;
123:2219–29
3.
ZhangJLuCX.Spontaneous regression of cervical intraepithelial neoplasia 2: a meta-analysis. Gynecol Obstet Invest2019;
84:562–7
4.
PalAKunduR.Human papillomavirus E6 and E7: the cervical cancer hallmarks and targets for.Front Microbiol2019;
10:3116
5.
MayrandMHDuarte-FrancoERodriguesIWalterSDHanleyJFerenczyARatnamSCoutleeFFrancoEL.Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer. N Engl J Med2007;
357:1579–88
6.
MukemSMengQSriplungHTangcharoensathienV.Low coverage and disparities of breast and cervical cancer screening in thai women: analysis of national representative household surveys. Asian Pac J Cancer Prev2015;
16:8541–51
7.
AlcaideMCheungMHillmanJRassekhSRDeyellRJBatistGKarsanAWyattAWJohnsonNScottDWMorinRD.Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR. Sci Rep2020;
10:12564
8.
KustanovichASchwartzRPeretzTGrinshpunA.Life and death of circulating cell-free DNA. Cancer Biol Ther2019;
20:1057–67
9.
BronkhorstAJUngererVHoldenriederS.The emerging role of cell-free DNA as a molecular marker for cancer management. Biomol Detect Quantif2019;
17:100087
10.
ChungTKHCheungTHYimSFYuMYChiuRWKLoKWKLeeIPCWongRRYLauKKMWangVWWorleyMJJrEliasKMFiasconeSJSmithDIBerkowitzRSWongYF.Liquid biopsy of PIK3CA mutations in cervical cancer in Hong Kong Chinese women. Gynecol Oncol2017;
146:334–9
11.
KimHJKimCYJinJBaeMKKimYHJuWKimYHKimSC.Aberrant single-minded homolog 1 methylation as a potential biomarker for cervical cancer. Diagn Cytopathol2018;
46:15–21
12.
PornthanakasemWShotelersukKTermrungruanglertWVoravudNNiruthisardSMutiranguraA.Human papillomavirus DNA in plasma of patients with cervical cancer. BMC Cancer2001;
1:2
13.
MazurekAMFiszer-KierzkowskaARutkowskiTSkladowskiKPierzynaMScieglinskaDWozniakGGlowackiGKawczynskiRMaluseckaE.Optimization of circulating cell-free DNA recovery for KRAS mutation and HPV detection in plasma. Cancer Biomark2013;
13:385–94
14.
GuYWanCQiuJCuiYJiangTZhuangZ.Circulating HPV cDNA in the blood as a reliable biomarker for cervical cancer: a meta-analysis. PLoS One2020;
15:e0224001
15.
JeannotEBecetteVCampitelliMCalmejaneMALappartientERuffESaadaSHolmesABelletDSastre-GarauX.Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma.J Pathol Clin Res2016;
2:201–9
16.
SathishNAbrahamPPeedicayilASridharanGJohnSShajiRVChandyG.HPV DNA in plasma of patients with cervical carcinoma. J Clin Virol2004;
31:204–9
17.
KayPAllanBDennyLHoffmanMWilliamsonAL.Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer. J Med Virol2005;
75:435–9
18.
DongSMPaiSIRhaSHHildesheimAKurmanRJSchwartzPEMortelRMcGowanLGreenbergMDBarnesWASidranskyD.Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol Biomarkers Prev2002;
11:3–6
19.
WidschwendterABlassnigAWiedemairAMuller-HolznerEMullerHMMarthC.Human papillomavirus DNA in sera of cervical cancer patients as tumor marker. Cancer Lett2003;
202:231–9
20.
YangHJLiuVWTsangPCYipAMTamKFWongLCNgTYNganHY.Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer. Int J Gynecol Cancer2004;
14:903–10
21.
GnanamonyMPeedicayilASubhashiniJRamTSRajasekarAGravittPAbrahamP.Detection and quantitation of HPV 16 and 18 in plasma of Indian women with cervical cancer. Gynecol Oncol2010;
116:447–51
22.
HindsonCMChevilletJRBriggsHAGallichotteENRufIKHindsonBJVessellaRLTewariM.Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods2013;
10:1003–5
23.
LiJMacdonaldJvon StettenF.Review: a comprehensive summary of a decade development of the recombinase polymerase amplification. Analyst2018;
144:31–67
24.
DaherRKStewartGBoissinotMBergeronMG.Recombinase polymerase amplification for diagnostic applications. Clin Chem2016;
62:947–58
25.
PowellMLBowlerFRMartinezAJGreenwoodCJArmesNPiepenburgO.New Fpg probe chemistry for direct detection of recombinase polymerase amplification on lateral flow strips. Anal Biochem2018;
543:108–15
26.
QiYYinQShaoYCaoMLiSChenHShenWRaoJLiJLiXSunYLinYDengYZengWZhengSLiuSLiY.Development of a rapid and visual nucleotide detection method for a Chinese epidemic strain of Orientia tsutsugamushi based on recombinase polymerase amplification assay and lateral flow test. Int J Infect Dis2018;
70:42–50
27.
ChaoCCBelinskayaTZhangZChingWM.Development of recombinase polymerase amplification assays for detection of Orientia tsutsugamushi or Rickettsia typhi. PLoS Negl Trop Dis2015;
9:e0003884
28.
ZhaoGWangHHouPHeCHeH.Rapid visual detection of Mycobacterium avium subsp. paratuberculosis by recombinase polymerase amplification combined with a lateral flow dipstick. J Vet Sci2018;
19:242–50
29.
CrannellZARohrmanBRichards-KortumR.Equipment-free incubation of recombinase polymerase amplification reactions using body heat. PLoS One2014;
9:e112146
30.
LillisLLehmanDSinghalMCCanteraJSingletonJLabarrePToyamaAPiepenburgOParkerMWoodROverbaughJBoyleDS.Non-instrumented incubation of a recombinase polymerase amplification assay for the rapid and sensitive detection of proviral HIV-1 DNA. PLoS One2014;
9:e108189
31.
KooKMWeeEJTrauM.Colorimetric TMPRSS2-ERG gene fusion detection in prostate cancer urinary samples via recombinase polymerase amplification. Theranostics2016;
6:1415–24
32.
LiuYLeiTLiuZKuangYLyuJWangQ.A novel technique to detect EGFR mutations in lung cancer. IJMS2016;
17:792
33.
MaBFangJWangYHeHDaiMLinWSuWZhangM.Isothermal method of a recombinase polymerase amplification assay for the detection of most common High-Risk human papillomavirus type 16 and type 18 DNA. Clin Lab2017;
63:27–38
34.
LiuLWangJGengYWangJLiRShiRYuanW.Equipment-free recombinase polymerase amplification assay using body heat for visual and rapid point-of-need detection of canine parvovirus 2. Mol Cell Probes2018;
39:41–6
35.
KangZStevanovicSHinrichsCSCaoL.Circulating cell-free DNA for metastatic cervical cancer detection, genotyping, and monitoring. Clin Cancer Res2017;
23:6856–62
36.
SpitzerMWildenhainJRappsilberJTyersM.BoxPlotR: a web tool for generation of box plots. Nat Methods2014;
11:121–2
37.
LandisJRKochGG.The measurement of observer agreement for categorical data. Biometrics1977;
33:159–74
38.
ChungCHGillisonML.Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res2009;
15:6758–62
39.
BoschFXBrokerTRFormanDMoscickiABGillisonMLDoorbarJSternPLStanleyMArbynMPoljakMCuzickJCastlePESchillerJTMarkowitzLEFisherWACanfellKDennyLAFrancoELStebenMKaneMASchiffmanMMeijerCJSankaranarayananRCastellsagueXKimJJBrotonsMAlemanyLAlberoGDiazMde SanjoseS, authors of ICOMCCoHPVI, Related Diseases Vaccine Volume S.Comprehensive control of human papillomavirus infections and related diseases. Vaccine2013;
31:H1–31
40.
IlahiNEAnwarSNoreenMHashmiSNMuradS.Detection of human papillomavirus-16 DNA in archived clinical samples of breast and lung cancer patients from North Pakistan. J Cancer Res Clin Oncol2016;
142:2497–502
41.
PianaAFSotgiuGMuroniMRCossu-RoccaPCastigliaPDe MiglioMR.HPV infection and triple-negative breast cancers: an Italian case–control study. Virol J2014;
11:190
42.
LiXGaoCYangYZhouFLiMJinQGaoL.Systematic review with Meta-analysis: the association between human papillomavirus infection and oesophageal cancer. Aliment Pharmacol Ther2014;
39:270–81
43.
IbragimovaMKTsyganovMMLitviakovNV.Human papillomavirus and colorectal cancer. Med Oncol2018;
35:140
44.
SmithJSLindsayLHootsBKeysJFranceschiSWinerRCliffordGM.Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer2007;
121:621–32
45.
MunozNBoschFXde SanjoseSHerreroRCastellsagueXShahKVSnijdersPJMeijerCJ.International Agency for Research on Cancer Multicenter Cervical Cancer Study G. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med2003;
348:518–27
46.
McBrideAAWarburtonA.The role of integration in oncogenic progression of HPV-associated cancers. PLoS Pathog2017;
13:e1006211
47.
JeonSAllen-HoffmannBLLambertPF.Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol1995;
69:2989–97
48.
Nkili-MeyongAAMoussavou-BoundzangaPLaboubaIKoumakpayiIHJeannotEDescorps-DeclereSSastre-GarauXLeroyEMBelembaogoEBerthetN.Genome-wide profiling of human papillomavirus DNA integration in liquid-based cytology specimens from a Gabonese female population using HPV capture technology. Sci Rep2019;
9:1504
49.
Gonzalez-MasiaJAGarcia-OlmoDGarcia-OlmoDC.Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology. Onco Targets Ther2013;
6:819–32
50.
Fernandez-LazaroDGarcia HernandezJLGarciaACCordova MartinezAMielgo-AyusoJCruz-HernandezJJ.Liquid biopsy as novel tool in precision medicine: origins, properties, identification and clinical perspective of cancer's biomarkers. Diagnostics2020;
10:215
51.
MaltoniRCasadioVRavaioliSFocaFTumedeiMMSalviSMartignanoFCalistriDRoccaASchironeAAmadoriDBravacciniS.Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer. Oncotarget2017;
8:16642–9
52.
RossiGMuZRademakerAWAustinLKStricklandKSCostaRLBNagyRJZagonelVTaxterTJBehdadAWehbeFHPlataniasLCGradisharWJCristofanilliM.Cell-free DNA and circulating tumor cells: comprehensive liquid biopsy analysis in advanced breast cancer. Clin Cancer Res2018;
24:560–8
53.
LapinMOltedalSTjensvollKBuhlTSmaalandRGarresoriHJavleMGlenjenNIAbelsethBKGiljeBNordgardO.Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer. J Transl Med2018;
16:300
54.
IemprideeTWiwithaphonSPiboonpraiKPratedratPKhumkhrongPJaprungDTemisakSLaiwejpithayaSChaopotongPDharakulT.Identification of reference genes for circulating long noncoding RNA analysis in serum of cervical cancer patients. FEBS Open Bio2018;
8:1844–54
55.
UnderhillHRKitzmanJOHellwigSWelkerNCDazaRBakerDNGligorichKMRostomilyRCBronnerMPShendureJ.Fragment length of circulating tumor DNA. PLoS Genet2016;
12:e1006162
56.
ChengFSuLQianC.Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer. Oncotarget2016;
7:48832–41
57.
SurajSDharCSrivastavaS.Circulating nucleic acids: an analysis of their occurrence in malignancies. Biomed Rep2017;
6:8–14
58.
CheungTHYimSFYuMYWorleyMJJrFiasconeSJChiuRWKLoKWKSiuNSSWongMCSYeungACMWongRRYChenZGEliasKMChungTKHBerkowitzRSWongYFChanPKS.Liquid biopsy of HPV DNA in cervical cancer. J Clin Virol2019;
114:32–6
59.
ZehirABenayedRShahRHSyedAMiddhaSKimHRSrinivasanPGaoJChakravartyDDevlinSMHellmannMDBarronDASchramAMHameedMDoganSRossDSHechtmanJFDeLairDFYaoJMandelkerDLChengDTChandramohanRMohantyASPtashkinRNJayakumaranGPrasadMSyedMHRemaABLiuZYNafaKBorsuLSadowskaJCasanovaJBacaresRKieckaIJRazumovaASonJBStewartLBaldiTMullaneyKAAl-AhmadieHVakianiEAbeshouseAAPensonAVJonssonPCamachoNChangMTWonHHGrossBEKundraRHeinsZJChenHWPhillipsSZhangHWangJOchoaAWillsJEubankMThomasSBGardosSMRealesDNGalleJDuranyRCambriaRAbidaWCercekAFeldmanDRGounderMMHakimiAAHardingJJIyerGJanjigianYYJordanEJKellyCMLoweryMAMorrisLGTOmuroAMRajNRazaviPShoushtariANShuklaNSoumeraiTEVargheseAMYaegerRColemanJBochnerBRielyGJSaltzLBScherHISabbatiniPJRobsonMEKlimstraDSTaylorBSBaselgaJSchultzNHymanDMArcilaMESolitDBLadanyiMBergerMF.Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med2017;
23:703–13
60.
MullerEBraultBHolmesALegrosAJeannotECampitelliMRousselinAGoardonNFrebourgTKriegerSCrouetHNicolasASastreXVaurDCasteraL.Genetic profiles of cervical tumors by high-throughput sequencing for personalized medical care. Cancer Med2015;
4:1484–93
61.
CocuzzaCEMartinelliMSinaFPianaASotgiuGDell'AnnaTMusumeciR.Human papillomavirus DNA detection in plasma and cervical samples of women with a recent history of low grade or precancerous cervical dysplasia. PLoS One2017;
12:e0188592
62.
HsuKFHuangSCHsiaoJRChengYMWangSPChouCY.Clinical significance of serum human papillomavirus DNA in cervical carcinoma. Obstet Gynecol2003;
102:1344–51
63.
MouliereFEl MessaoudiSPangDDritschiloAThierryAR.Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer. Mol Oncol2014;
8:927–41
SidstedtMHedmanJRomsosELWaitaraLWadsoLSteffenCRVallonePMRadstromP.Inhibition mechanisms of hemoglobin, immunoglobulin G, and whole blood in digital and real-time PCR. Anal Bioanal Chem2018;
410:2569–83
66.
ChansaenrojJJunyangdikulPChinchaiTSwangvareeSKaralakAGemmaNPoovorawanY.Large scale study of HPV genotypes in cervical cancer and different cytological cervical specimens in Thailand. J Med Virol2014;
86:601–7
67.
TsakogiannisDGortsilasPKyriakopoulouZRuetherIGDimitriouTGOrfanoudakisGMarkoulatosP.Sites of disruption within E1 and E2 genes of HPV16 and association with cervical dysplasia. J Med Virol2015;
87:1973–80
68.
SaetiewCLimpaiboonTJearanaikoonPDaduangSPientongCKerdsinADaduangJ.Rapid detection of the most common high-risk human papillomaviruses by loop-mediated isothermal amplification. J Virol Methods2011;
178:22–30
69.
SatohTMatsumotoKFujiiTSatoOGemmaNOnukiMSaitoHAokiDHiraiYYoshikawaH.Rapid genotyping of carcinogenic human papillomavirus by loop-mediated isothermal amplification using a new automated DNA test (clinichip HPV). J Virol Methods2013;
188:83–93
70.
YangYQinXWangGJinJShangYZhangZ.Development of an isothermal amplification-based assay for rapid visual detection of an Orf virus. Virol J2016;
13:46
MaheshwariYSelvarajVHajeriSYokomiR.Application of droplet digital PCR for quantitative detection of Spiroplasma citri in comparison with real time PCR. PLoS One2017;
12:e0184751
73.
ZhaoYXiaQYinYWangZ.Comparison of droplet digital PCR and quantitative PCR assays for quantitative detection of Xanthomonas citri subsp. citri. PLoS One2016;
11:e0159004
74.
JohanssonGAnderssonDFilgesSLiJMuthAGodfreyTEStahlbergA.Considerations and quality controls when analyzing cell-free tumor DNA. Biomol Detect Quantif2019;
17:100078
75.
PiepenburgOWilliamsCHStempleDLArmesNA.DNA detection using recombination proteins. PLoS Biol2006;
4:e204
76.
HuJHuangRSunYWeiXWangYJiangCGengYSunXJingJGaoHWangZDongC.Sensitive and rapid visual detection of Salmonella typhimurium in milk based on recombinase polymerase amplification with lateral flow dipsticks. J Microbiol Methods2019;
158:25–32
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
